Analyst Ratings For TapImmune (NASDAQ:TPIV)
Today, WBB Securities initiated coverage on TapImmune (NASDAQ:TPIV) with a Speculative Buy with a price target of $5.00.
Some recent analyst ratings include
- 3/16/2018-WBB Securities initiated coverage with a Speculative Buy rating.
Recent Trading Activity for TapImmune (NASDAQ:TPIV)
Shares of TapImmune closed the previous trading session at 3.60 down -0.07 1.91% with 16426 shares trading hands.